Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

Completed

Conditions studied: Multiple Sclerosis, Relapsing-Remitting

In brief

The primary objective of this study is to assess adherence and persistence to BETASERON therapy in patients who are using the BETACONNECT auto-injector device (BETACONNECT device). The secondary objective of this study is to assess patient-reported satisfaction with the BETACONNECT device.

Key facts

Study ID

NCT02652091

Run by

Bayer

People needed

146

Starts

2016-02-05

Expected to finish

2017-09-13

Last updated by the study team

2018-09-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and females greater than or equal to 18 years of age
• Diagnosis of RRMS according to revised McDonald Criteria (2010) or (CIS)
• Prescribed BETASERON (note: decision to treat with BETASERON must be made independent of participation in this study)
• Confirmation of insurance coverage for BETASERON treatment
• Access to a personal computer to complete online patient satisfaction survey at Week 6

You may not qualify if…

• Currently enrolled in a clinical trial or other observational study for Multiple Sclerosis treatment
• Documented substance abuse within the previous 6 months prior to study enrollment
• Any major laboratory value abnormality that the investigator believes would preclude the patient from participating in the study
• Any medical disorder, condition or history that in the opinion of the investigator would impair the patient's ability to participate in or complete the study
• Pregnant or nursing

Where it is running

• Study site — Cullman, Alabama, United States
• Study site — Boca Raton, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Fulton, Maryland, United States
• Study site — Foxborough, Massachusetts, United States
• Study site — Deckerville, Michigan, United States
• Study site — St Louis, Missouri, United States
• Study site — Stratford, New Jersey, United States
• Study site — Teaneck, New Jersey, United States
• Study site — Staten Island, New York, United States
• Study site — Medford, Oregon, United States
• Study site — Medford, Oregon, United States
• Study site — Bala-Cynwyd, Pennsylvania, United States
• Study site — Lititz, Pennsylvania, United States
• Study site — Franklin, Tennessee, United States
• Study site — Memphis, Tennessee, United States
• Study site — Nashville, Tennessee, United States
• Study site — Lubbock, Texas, United States
• Study site — Round Rock, Texas, United States
• Study site — Fairfax, Virginia, United States
• Study site — Virginia Beach, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.